Liver disease complicating the management of acute leukemia during remission

James O. Armitage, C. Patrick Burns, Thomas H. Kent

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Eight adults who developed persisting liver function abnormalities during remission from acute leukemia (6 acute nonlymphoblatic leukemia and 2 acute lymphoblastic leukemia) are reported. These patients constituted 20% of the adults with acute leukemia attaining remission over the time period studied. Although we were unable to be absolutely certain of the etiology of the liver dysfunction, the following findings characterize the problem: 1) onset following red blood cell and platelet transfusions in all cases; 2) minimal symptoms and signs except for transient episodes of jaundice; 3) fluctuating, but often marked, increases in liver transaminases; 4) no other consistent laboratory abnormalities; 5) liver biopsies showing varying degrees of inflammation; 6) a consistent decrease in transaminase levels following pulse chemotherapy; 7) absence of progression of abnormalities during the observation period. This group of patients did not have a worse prognosis than patients with normal liver function. We feel that it is important to recognize this entity and to not withhold antileukemic therapy.

Original languageEnglish (US)
Pages (from-to)737-742
Number of pages6
JournalCancer
Volume41
Issue number2
DOIs
StatePublished - Feb 1978

Fingerprint

Disease Management
Liver Diseases
Leukemia
Liver
Transaminases
Erythrocyte Transfusion
Platelet Transfusion
Jaundice
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Signs and Symptoms
Observation
Inflammation
Biopsy
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Liver disease complicating the management of acute leukemia during remission. / Armitage, James O.; Burns, C. Patrick; Kent, Thomas H.

In: Cancer, Vol. 41, No. 2, 02.1978, p. 737-742.

Research output: Contribution to journalArticle

Armitage, James O. ; Burns, C. Patrick ; Kent, Thomas H. / Liver disease complicating the management of acute leukemia during remission. In: Cancer. 1978 ; Vol. 41, No. 2. pp. 737-742.
@article{1e4d13ad27184368a58cfc88bcdddf43,
title = "Liver disease complicating the management of acute leukemia during remission",
abstract = "Eight adults who developed persisting liver function abnormalities during remission from acute leukemia (6 acute nonlymphoblatic leukemia and 2 acute lymphoblastic leukemia) are reported. These patients constituted 20{\%} of the adults with acute leukemia attaining remission over the time period studied. Although we were unable to be absolutely certain of the etiology of the liver dysfunction, the following findings characterize the problem: 1) onset following red blood cell and platelet transfusions in all cases; 2) minimal symptoms and signs except for transient episodes of jaundice; 3) fluctuating, but often marked, increases in liver transaminases; 4) no other consistent laboratory abnormalities; 5) liver biopsies showing varying degrees of inflammation; 6) a consistent decrease in transaminase levels following pulse chemotherapy; 7) absence of progression of abnormalities during the observation period. This group of patients did not have a worse prognosis than patients with normal liver function. We feel that it is important to recognize this entity and to not withhold antileukemic therapy.",
author = "Armitage, {James O.} and Burns, {C. Patrick} and Kent, {Thomas H.}",
year = "1978",
month = "2",
doi = "10.1002/1097-0142(197802)41:2<737::AID-CNCR2820410246>3.0.CO;2-7",
language = "English (US)",
volume = "41",
pages = "737--742",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Liver disease complicating the management of acute leukemia during remission

AU - Armitage, James O.

AU - Burns, C. Patrick

AU - Kent, Thomas H.

PY - 1978/2

Y1 - 1978/2

N2 - Eight adults who developed persisting liver function abnormalities during remission from acute leukemia (6 acute nonlymphoblatic leukemia and 2 acute lymphoblastic leukemia) are reported. These patients constituted 20% of the adults with acute leukemia attaining remission over the time period studied. Although we were unable to be absolutely certain of the etiology of the liver dysfunction, the following findings characterize the problem: 1) onset following red blood cell and platelet transfusions in all cases; 2) minimal symptoms and signs except for transient episodes of jaundice; 3) fluctuating, but often marked, increases in liver transaminases; 4) no other consistent laboratory abnormalities; 5) liver biopsies showing varying degrees of inflammation; 6) a consistent decrease in transaminase levels following pulse chemotherapy; 7) absence of progression of abnormalities during the observation period. This group of patients did not have a worse prognosis than patients with normal liver function. We feel that it is important to recognize this entity and to not withhold antileukemic therapy.

AB - Eight adults who developed persisting liver function abnormalities during remission from acute leukemia (6 acute nonlymphoblatic leukemia and 2 acute lymphoblastic leukemia) are reported. These patients constituted 20% of the adults with acute leukemia attaining remission over the time period studied. Although we were unable to be absolutely certain of the etiology of the liver dysfunction, the following findings characterize the problem: 1) onset following red blood cell and platelet transfusions in all cases; 2) minimal symptoms and signs except for transient episodes of jaundice; 3) fluctuating, but often marked, increases in liver transaminases; 4) no other consistent laboratory abnormalities; 5) liver biopsies showing varying degrees of inflammation; 6) a consistent decrease in transaminase levels following pulse chemotherapy; 7) absence of progression of abnormalities during the observation period. This group of patients did not have a worse prognosis than patients with normal liver function. We feel that it is important to recognize this entity and to not withhold antileukemic therapy.

UR - http://www.scopus.com/inward/record.url?scp=0017834978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017834978&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(197802)41:2<737::AID-CNCR2820410246>3.0.CO;2-7

DO - 10.1002/1097-0142(197802)41:2<737::AID-CNCR2820410246>3.0.CO;2-7

M3 - Article

C2 - 630548

AN - SCOPUS:0017834978

VL - 41

SP - 737

EP - 742

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 2

ER -